BlackRock, Inc. 13D and 13G filings for TherapeuticsMD, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-01-31 5:49 pm Purchase |
2021-12-31 | 13G | TherapeuticsMD, Inc. TXMD |
BlackRock Inc. BLK |
497,896 5.900% |
69,511![]() (+16.23%) |
Filing |
2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | TherapeuticsMD, Inc. TXMD |
BlackRock Inc. BLK |
428,385 7.100% |
63,203![]() (+17.31%) |
Filing |